Structural, functional and autonomic changes in the cardiovascular system in growth hormone deficient patients

Doğan Erdoğan1, Tufan Tükek, Ferihan Aral

  • 1Department of Cardiology, Istanbul University, Medical Faculty of Istanbul, Turkey.

Insights

Growth hormone deficiency (GHD) in adults is linked to reduced heart size and impaired autonomic function, indicated by lower heart rate variability (HRV). These changes may contribute to the increased cardiovascular risk observed in GHD patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Autonomic Neuroscience

Background:

  • Growth hormone deficiency (GHD) is associated with elevated cardiovascular mortality rates.
  • Understanding cardiac structural and functional changes in GHD is crucial for risk assessment.
  • Autonomic nervous system function, assessed via heart rate variability (HRV), may be impacted by GHD.

Purpose of the Study:

  • To analyze structural and functional cardiac alterations in adult patients with GHD.
  • To investigate the relationship between cardiac changes and autonomic function (HRV) in GHD.
  • To identify potential mechanisms underlying increased cardiovascular risk in GHD.

Main Methods:

  • Comparison of 11 untreated GHD patients with 15 age- and sex-matched healthy controls.
  • Echocardiography to assess cardiac structure and function.
  • Heart rate variability (HRV) analysis for autonomic function assessment.
  • Exercise testing to evaluate functional capacity.

Main Results:

  • GHD patients exhibited significantly lower exercise duration and metabolic equivalent (MET) values.
  • Echocardiography revealed reduced interventricular septum diameter, posterior wall thickness, and left ventricle mass index in GHD patients.
  • Left ventricular ejection fraction was significantly lower in GHD patients.
  • HRV analysis showed decreased time and frequency domain parameters (SDNN, SDANN, VLF, LF, LF/HF) in GHD patients.
  • A significant correlation was found between left ventricle diastolic diameter and LF (a measure of sympathetic activity).

Conclusions:

  • GHD is associated with decreased left ventricle mass and impaired cardiac function.
  • GHD patients demonstrate reduced sympathetic components of HRV.
  • These cardiac and autonomic alterations in GHD may contribute to the heightened cardiovascular risk observed in this population.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...